Parabase Genomics

About:

Parabase Genomics is a molecular diagnostics company that focuses on the development of treatments for genetic disorders.

Website: http://www.parabasegenomics.com

Twitter/X: SavingNewborns

Top Investors: Walnut Venture Associates, SXE Ventures

Description:

Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with genetic disorders are diagnosed and treated. The Company’s NewbornDx™ test is designed to guide the differential diagnosis of common symptomology found in neonates. It allows a physician to utilize one test to provide an accurate molecular profile on 500+ newborn related genes using dried blood spots within 10 days. Physicians no longer need to depend on severe phenotypes to nominate a single gene test for a given disorder.

Total Funding Amount:

$2.97M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Hardwick, Massachusetts, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)parabasegenomics.com

Founders:

Andy Bhattacharjee, Gabor Bethlendy

Number of Employees:

1-10

Last Funding Date:

2014-11-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai